Page 108 - Haematologica April 2020

S. Altamura et al.
40. Kiermayer C, Conrad M, Schneider M, Schmidt J, Brielmeier M. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen cit- rate. Genesis. 2007;45(1):11-16.
41. Rathkolb B, Fuchs H, Gailus-Durner V, Aigner B, Wolf E, Hrabe de Angelis M. Blood collection from mice and hematolog- ical analyses on mouse blood. Curr Protoc Mouse Biol. 2013;3(2):101-119.
42. Lenox LE, Perry JM, Paulson RF. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood. 2005;105(7):2741-2748.
43. Harandi OF, Hedge S, Wu DC, McKeone D, Paulson RF. Murine erythroid short-term radioprotection requires a BMP4-depen- dent, self-renewing population of stress erythroid progenitors. J Clin Invest. 2010;120(12):4507-4519.
44. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood. 2008;112(3):470-478.
45. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277.
46. Wortmann M, Schneider M, Pircher J, et al. Combined deficiency in glutathione perox- idase 4 and vitamin E causes multiorgan thrombus formation and early death in mice. Circ Res. 2013;113(4):408-417.
47. Matsushita M, Freigang S, Schneider C, Conrad M, Bornkamm GW, Kopf M. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med. 2015;212(4):555-568.
48. Carlson BA, Tobe R, Yefremova E, et al. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 2016;9:22-31.
49. Chen K, Liu J, Heck S, et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A. 2009; 106(41):17413-17418.
50. Marsee DK, Pinkus GS, Yu H. CD71 (trans- ferrin receptor): an effective marker for ery- throid precursors in bone marrow biopsy specimens. Am J Clin Pathol. 2010; 134(3):429-435.
51. Rivella S. Ineffective erythropoiesis and thalassemias. Curr Opin Hematol. 2009; 16(3):187-194.
52. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of ery- throferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46(7):678-684.
53. Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317- 331.
54. Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81-90.
55. Canli O, Alankus YB, Grootjans S, et al. Glutathione peroxidase 4 prevents necrop- tosis in mouse erythroid precursors. Blood. 2016;127(1):139-148.
56. Frudd K, Burgoyne T, Burgoyne JR. Oxidation of Atg3 and Atg7 mediates inhi- bition of autophagy. Nat Commun. 2018;9(1):95.
57. Kautz L, Jung G, Du X, et al. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta- thalassemia. Blood. 2015;126(17):2031- 2037.
58. Tappel AL. Unsaturated lipide oxidation
catalyzed by hematin compounds. J Biol
Chem. 1955;217(2):721-733.
59. Rachmilewitz EA, Shohet SB, Lubin BH.
Lipid membrane peroxidation in beta-tha-
lassemia major. Blood. 1976;47(3):495-505. 60. Rachmilewitz EA, Shifter A, Kahane I. Vitamin E deficiency in beta-thalassemia major: changes in hematological and bio- chemical parameters after a therapeutic trial with alpha-tocopherol. Am J Clin Nutr.
1979;32(9):1850-1858.
61. Rachmilewitz EA, Kornberg A, Acker M.
Vitamin E deficiency due to increased con- sumption in beta-thalassemia and in Gaucher's disease. Ann N Y Acad Sci. 1982; 393:336-347.
62. Fibach E, Rachmilewitz EA. The role of antioxidants and iron chelators in the treat- ment of oxidative stress in thalassemia. Ann N Y Acad Sci. 2010;1202:10-16.
63. Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood. 1996;88(9):3608-3614.
64. Giardini O, Cantani A, Donfrancesco A, et al. Biochemical and clinical effects of vita- min E administration in homozygous beta- thalassemia. Acta Vitaminol Enzymol. 1985;7(1-2):55-60.
65. Tesoriere L, D'Arpa D, Butera D, et al. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radic Res. 2001;34(5):529-540.
66. Holm TM, Braun A, Trigatti BL, et al. Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood. 2002;99(5):1817- 1824.
950
haematologica | 2020; 105(4)